We are live on ! Find out more
EVO icon

Evotec
EVO

19 hedge funds and large institutions have $14.5M invested in Evotec in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 9 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.7% less ownership

Funds ownership: 1.47% → 0.77% (-0.7%)

14% less funds holding

Funds holding: 22 → 19 (-3)

31% less capital invested

Capital invested by funds: $21.1M → $14.5M (-$6.53M)

67% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 9

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
19
Holders Change
-3
Holders Change %
-13.64%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
9
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DA
DCF Advisers
Connecticut
+$118K
2
Optiver Holding
Optiver Holding
Netherlands
+$63.1K
3
Bank of America
Bank of America
North Carolina
+$4.62K
4
Morgan Stanley
Morgan Stanley
New York
+$2.84K

Top Sellers

Rank Fund Capital Flow
1
AG
Artal Group
Luxembourg
-$9.3M
2
Renaissance Technologies
Renaissance Technologies
New York
-$255K
3
Jane Street
Jane Street
New York
-$162K
4
OMC
Old Mission Capital
Illinois
-$108K
5
Citadel Advisors
Citadel Advisors
Florida
-$107K
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$7.96M – – –
Millennium Management
2
Millennium Management
New York
$2.49M -$24.1K -2,518 -1%
Zurich Cantonal Bank
3
Zurich Cantonal Bank
Switzerland
$2.29M -$67.9K -7,103 -3%
Jane Street
4
Jane Street
New York
$570K -$162K -16,911 -24%
Morgan Stanley
5
Morgan Stanley
New York
$489K +$2.84K +297 +0.6%
Optiver Holding
6
Optiver Holding
Netherlands
$298K +$63.1K +6,599 +31%
OMC
7
Old Mission Capital
Illinois
$138K -$108K -11,309 -46%
DA
8
DCF Advisers
Connecticut
$129K +$118K +12,388 New
Fidelity Investments
9
Fidelity Investments
Massachusetts
$57.8K -$20.8K -2,175 -29%
BlackRock
10
BlackRock
New York
$54.8K -$10.9K -1,138 -18%
Bank of America
11
Bank of America
North Carolina
$46.1K +$4.62K +483 +12%
UBS Group
12
UBS Group
Switzerland
$13.9K -$19.2K -2,006 -60%
WT
13
Washington Trust
Rhode Island
$4.4K – – –
US Bancorp
14
US Bancorp
Minnesota
$2.61K -$1.7K -178 -42%
S
15
SignatureFD
Georgia
$1.5K -$1.97K -206 -59%
LC
16
Lindbrook Capital
California
$752 – – –
PA
17
Parallel Advisors
California
$732 – – –
BIA
18
Bell Investment Advisors
California
$230 – – –
AG
19
Artal Group
Luxembourg
– -$9.3M -1,149,425 Closed
Renaissance Technologies
20
Renaissance Technologies
New York
– -$255K -31,509 Closed
Citadel Advisors
21
Citadel Advisors
Florida
– -$107K -13,284 Closed
Geode Capital Management
22
Geode Capital Management
Massachusetts
– -$107K -13,238 Closed

EVO Hedge Fund Activity: Q1 2023 in Review

19 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Evotec (EVO) for Q1 2023, worth a combined $14.5M — down 31% from $21.1M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of EVO and 1 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 3 added.

The largest buyer was DCF Advisers, opening a new position worth an estimated $118K. The largest seller was Artal Group, exiting entirely with an estimated $9.3M sold.

  • 19 institutional investors held Evotec (EVO) as of Q1 2023, down from 22 in Q4 2022.
  • Funds reported $14.5M of Evotec stock for Q1 2023, down 31% quarter-over-quarter.
  • 1 fund opened new Evotec positions in Q1 2023 and 4 closed out, a net change of -3 holders.
  • The largest Evotec buyer in Q1 2023 was DCF Advisers, an estimated $118K added.
  • The largest Evotec seller in Q1 2023 was Artal Group, an estimated $9.3M sold.

Based on aggregated 13F filings for Q1 2023.